Back to Search Start Over

Benzoisoquinolinediones as Potent and Selective Inhibitors of BRPF2 and TAF1/TAF1L Bromodomains.

Authors :
Bouché, Léa
Christ, Clara D.
Siegel, Stephan
Fernández-Montalván, Amaury E.
Holton, Simon J.
Fedorov, Oleg
ter Laak, Antonius
Sugawara, Tatsuo
Stöckigt, Detlef
Tallant, Cynthia
Bennett, James
Monteiro, Octovia
Díaz-Sáez, Laura
Siejka, Paulina
Meier, Julia
Pütter, Vera
Weiske, Jörg
Müller, Susanne
Huber, Kilian V. M.
Hartung, Ingo V.
Source :
Journal of Medicinal Chemistry. 5/11/2017, Vol. 60 Issue 9, p4002-4022. 21p.
Publication Year :
2017

Abstract

Bromodomains (BD) are readers of lysine acetylation marks present in numerous proteins associated with chromatin. Here we describe a dual inhibitor of the bromodomain and PHD finger (BRPF) family member BRPF2 and the TATA box binding protein-associated factors TAF1 and TAF1L. These proteins are found in large chromatin complexes and play important roles in transcription regulation. The substituted benzoisoquinolinedione series was identified by high-throughput screening, and subsequent structure-activity relationship optimization allowed generation of low nanomolar BRPF2 BD inhibitors with strong selectivity against BRPF1 and BRPF3 BDs. In addition, a strong inhibition of TAF1/TAF1L BD2 was measured for most derivatives. The best compound of the series was BAY-299, which is a very potent, dual inhibitor with an IC50 of 67 nM for BRPF2 BD, 8 nM for TAF1 BD2, and 106 nM for TAF1L BD2. Importantly, no activity was measured for BRD4 BDs. Furthermore, cellular activity was evidenced using a BRPF2- or TAF1-histone H3.3 or H4 interaction assay. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
00222623
Volume :
60
Issue :
9
Database :
Academic Search Index
Journal :
Journal of Medicinal Chemistry
Publication Type :
Academic Journal
Accession number :
123053038
Full Text :
https://doi.org/10.1021/acs.jmedchem.7b00306